ChitogenX
ChitogenX Inc. is a clinical-stage orthopedic biotechnology company based in Quebec, Canada, developing a biologic therapy for rotator cuff tear repair. The company is pre-revenue, operating with 1-10 employees and is publicly listed on the CNSX under CHGX.
- Company typePrivate
- Founded2015
- HeadquartersQuebec, Canada
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
ChitogenX firmographics
Firmographics- Name
- ChitogenX
- Legal name
- ChitogenX Inc.
- Website
- https://chitogenx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- ChitogenX Inc. is a clinical-stage orthopedic biotechnology company based in Quebec, Canada, developing a biologic therapy for rotator cuff tear repair. The company is pre-revenue, operating with 1-10 employees and is publicly listed on the CNSX under CHGX.
- Ownership category
- akta.pro rank
ChitogenX industry classification
Industry- Product category
- Orthopedic Biologics
- NAICS
- Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)
Keywords
Where ChitogenX is headquartered
LocationHeadquarters
- HQ city
- Quebec
- HQ country
- Canada
- HQ region
- North America
Markets served
ChitogenX business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
ChitogenX product offering
Product offeringCore offering
ChitogenX Inc. is a clinical-stage orthopedic biotechnology company developing a biologic therapy for rotator cuff tear repair. The lead asset is in Phase I/II clinical trials, with the company headquartered in Quebec, Canada and publicly listed on the Canadian Securities Exchange (cnsx:CHGX).
Differentiator
Problem solved
Functional benefit
Companies that use ChitogenX
Customer profileIdeal customer profiles1 record
ChitogenX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ChitogenX partnerships and signals
Strategic signalScale indicators3 records
ChitogenX competitors and assessment
Company assessmentMarket position
Customer concentration
ChitogenX social profiles
Digital presenceChitogenX financial estimates
Financial estimateRevenue estimate
Valuation estimate
ChitogenX leadership team
Management profileNumber of profiles
Profiles4 records
ChitogenX funding detail
Funding detailFunding overview
Funding rounds5 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ChitogenX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ChitogenX
What does ChitogenX do?
ChitogenX Inc. is a clinical-stage orthopedic biotechnology company developing a biologic therapy for rotator cuff tear repair. The lead asset is in Phase I/II clinical trials, with the company headquartered in Quebec, Canada and publicly listed on the Canadian Securities Exchange (cnsx:CHGX).
Is ChitogenX a public or private company?
ChitogenX is a private company. It is classified as public and is currently operating.
When was ChitogenX founded?
ChitogenX was founded in 2015. It employs 1 to 10 people.
Where is ChitogenX based?
ChitogenX is headquartered in Quebec, Canada, in the North America region.
Does ChitogenX have an API?
No public API is recorded for ChitogenX.
What industry is ChitogenX in?
ChitogenX's product category is Orthopedic Biologics. Its primary akta.pro industry code is HLAHAEAG, Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM). Its NAICS code is 621511 and its SIC code is 2835.